Maynard Um
-
-
-
-
-
-
-
JPMorgan Downgrades Pliant Therapeutics (PLRX) to Underweight
-
-
-
-
-
-
-
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Pliant Therapeutics - PLRX
-
-
-
-
-
-
-
Cantor Fitzgerald Reinstates Pliant Therapeutics (PLRX) at Neutral
-
-
-
-
-
-
-
JPMorgan Downgrades Pliant Therapeutics (PLRX) to Neutral
-
-
-
-
-
-
-
Pliant Therapeutics Inc. (PLRX) Provides Update on BEACON-IPF
-
-
-
-
-
-
-
Aligos Therapeutics (ALGS) Strengthens Senior Leadership Team with the Appointment of Hardean Achneck, MD as Chief Medical Officer
-
-
-
-
-
-
-
TD Cowen Reiterates Buy Rating on Pliant Therapeutics (PLRX)
-
401,453 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

